| CD4+ count–guided interruption of antiretroviral treatment Strategies for Management of Antiretroviral Therapy (SMART) Study Group New England Journal of Medicine 355 (22), 2283-2296, 2006 | 2272 | 2006 |
| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 1892 | 2003 |
| Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies M Egger, M May, G Chêne, AN Phillips, B Ledergerber, F Dabis, ... The Lancet 360 (9327), 119-129, 2002 | 1820 | 2002 |
| Initiation of antiretroviral therapy in early asymptomatic HIV infection Insight Start Study Group New England Journal of Medicine 373 (9), 795-807, 2015 | 1734 | 2015 |
| Meta-analysis: principles and procedures M Egger, GD Smith, AN Phillips Bmj 315 (7121), 1533-1537, 1997 | 1649 | 1997 |
| Class of antiretroviral drugs and the risk of myocardial infarction DAD Study Group New England Journal of Medicine 356 (17), 1723-1735, 2007 | 1574 | 2007 |
| Changing patterns of mortality across Europe in patients infected with HIV-1 A Mocroft, S Vella, TL Benfield, A Chiesi, V Miller, P Gargalianos, ... The Lancet 352 (9142), 1725-1730, 1998 | 1533 | 1998 |
| Decline in the AIDS and death rates in the EuroSIDA study: an observational study A Mocroft, B Ledergerber, C Katlama, O Kirk, P Reiss, AA Monforte, ... The Lancet 362 (9377), 22-29, 2003 | 1461 | 2003 |
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study S Collins, T Mertenskoetter, E Loeliger, R Tressler, I Weller, N Friis-Møller, ... Archives of internal medicine 166 (15), 1632-1641, 2006 | 1275 | 2006 |
| Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study N Friis-Møller, R Weber, P Reiss, R Thiébaut, O Kirk, AA Monforte, ... Aids 17 (8), 1179-1193, 2003 | 1184 | 2003 |
| Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial S McCormack, DT Dunn, M Desai, DI Dolling, M Gafos, R Gilson, ... The Lancet 387 (10013), 53-60, 2016 | 1005 | 2016 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration D: A: D Study Group The Lancet 371 (9622), 1417-1426, 2008 | 958 | 2008 |
| Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies When To Start Consortium The Lancet 373 (9672), 1352-1363, 2009 | 918 | 2009 |
| Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy AJ Rodger, V Cambiano, T Bruun, P Vernazza, S Collins, J Van Lunzen, ... Jama 316 (2), 171-181, 2016 | 714 | 2016 |
| Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients AA Monforte, AC Lepri, G Rezza, P Pezzotti, A Antinori, AN Phillips, ... Aids 14 (5), 499-507, 2000 | 650 | 2000 |
| HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity SG Deeks, AN Phillips Bmj 338, a3172, 2009 | 641 | 2009 |
| Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse … SW Worm, C Sabin, R Weber, P Reiss, W El-Sadr, F Dabis, S De Wit, ... The Journal of infectious diseases 201 (3), 318-330, 2010 | 635 | 2010 |
| Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ... The Lancet 384 (9939), 241-248, 2014 | 585 | 2014 |
| AIDS across Europe, 1994–98: the EuroSIDA study A Mocroft, C Katlama, AM Johnson, C Pradier, F Antunes, F Mulcahy, ... The Lancet 356 (9226), 291-296, 2000 | 574 | 2000 |
| Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study Strategies for Management of Antiretroviral Therapy (SMART) Study Group The Journal of infectious diseases 197 (8), 1133-1144, 2008 | 500 | 2008 |
